Avinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR) in a report released on Thursday morning. The brokerage issued a hold rating on the medical device company’s stock.

Avinger Stock Performance

NASDAQ AVGR opened at $0.39 on Thursday. Avinger has a 52 week low of $0.36 and a 52 week high of $5.45. The stock has a market capitalization of $1.29 million, a P/E ratio of -0.04 and a beta of 1.09. The stock has a fifty day moving average of $0.72 and a 200-day moving average of $0.93.

Avinger (NASDAQ:AVGR) last announced its quarterly earnings data on Thursday, November 7th. The medical device company reported ($1.82) EPS for the quarter, topping analysts’ consensus estimates of ($2.03) by $0.21. Avinger had a negative return on equity of 5,527.11% and a negative net margin of 261.06%. The firm had revenue of $1.65 million during the quarter, compared to analyst estimates of $1.60 million. During the same period last year, the company earned ($2.92) earnings per share. Equities research analysts forecast that Avinger will post -4.69 earnings per share for the current fiscal year.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.